Dr. John R. “Jack” Fowle III is the principal of Science to Inform, LLC, serving as an independent consultant advising clients on the use of science to inform decisions regarding environmental risk and in the development and use of alternatives for animal testing.
Prior to 2012, he was the Deputy Director of the U.S. Environmental Protection Agency’s (EPA) Health Effects Division in the Office of Pesticide Programs (OPP) in Washington, DC. He was responsible for directing the health risk assessment activities supporting the re-registration of existing pesticides as well as managed the integration of new toxicological approaches into OPP’s human health risk assessments. Before OPP, he was Director of EPA’s Neurotoxicology Division, as well as Assistant Laboratory Director, at the National Health and Environmental Effects Research Lab (NHEERL) in Research Triangle Park, NC helping to develop alternatives to animal approaches and to establish the Agency’s computational toxicology program. He has served as Deputy Director of EPA’s Science Advisory Board and as the Science Advisor to U.S. Senator Daniel Patrick Moynihan.
Since retiring from EPA, he serves on the Board of Directors for the Institute of In Vitro Sciences in Gaithersburg, MD, is President of the Board of Trustees for the Evidence Based Toxicology Consortium and is an AltTox Editor. He is Councilor for the American Society for Cellular and Computational Toxicology as well as Past President of the Society of Toxicology’s In Vitro and Alternative Methods Specialty section. He received his baccalaureate and doctoral degrees in genetics from George Washington University in Washington, D.C. and he is a board certified toxicologist.
Dr. Hayes holds appointments at Spherix Consulting, Harvard University, Michigan State University and University of Massachusetts. Previous positions include Vice-President at the Gillette Company and RJR Nabisco, and Director at Rohm & Haas, a specialty chemical manufacturer. Dr. Hayes was also a professor at Alabama, Mississippi and Wake Forest Universities. Dr. Hayes currently serves on the FDA Food Committee and is registered toxicologist in EU and certified nutrition specialist.
Throughout his career, Dr. Hayes has served on numerous boards and committees, including the NAS, NIH, FDA, EPS and DOD. He is past Secretary-General of IUTOX, past treasurer of American Board of Toxicology, past president of the American College of Toxicology, the Toxicology Education Foundation, the Academy of Toxicological Sciences and past councilor of Society of Toxicology. He is diplomate of the American Board of Toxicology, the Academy of Toxicological Sciences, the American Board of Forensic Medicine, the American Board of Forensic Examiners, and Fellow of the Academy of Toxicological Sciences, the Royal Society of Biology, the American College of Forensic Examiners, and the American College of Nutrition.
Dr. Hayes has authored 260 peer reviewed publications, and was editor of Hayes’ Principles and Methods of Toxicology, Human and Experimental Toxicology, Cutaneous and Ocular Toxicology, Toxicology Research and Application, and editor emeritus for Food and Chemical Toxicology.
Well recognized in the field, Dr. Hayes has received many industry awards, including the Society of Toxicology Merit Award, the Mid-Atlantic Society of Toxicology Ambassador Award, the American College of Toxicology Distinguished Scientist Award, and the International Dose-Response Society Outstanding Leadership Award. Dr. Hayes was named a Distinguished Fellow by the American College of Toxicology and a Fellow by the American Association for the Advancement of Science.
Dr. Hayes holds degrees from Auburn University and Emory University, was NSF Fellow at Auburn, NIH Individual Fellow at Vanderbilt, NATO Senior Scientist in UK, and NIH Research Career Development Awardee.
James M. Hoffman, Esq., a 15 year member of the IIVS Board of Directors, filed the original documents to establish IIVS as a legal entity in the State of Maryland as well as prepared the documentation with the Internal Revenue Service for IIVS to hold its 501(c)(3) status. Mr. Hoffman is a business attorney who represents various types of closely held entities. As such, he has represented clients in purchases and sales of assets and businesses, leases, contractual matters, employment issues and day to day operational issues for clients. He also has a broad range of experience in litigation including complex commercial litigation, bankruptcy issues, intellectual property disputes and collection actions in state court and Bankruptcy Court. Mr. Hoffman received his J.D. from the University of Maryland in 1985, and he is licensed to practice law in Maryland and the District of Columbia.
Dr. Richard E. Kouri is the Chief Evangelist, Center for Innovation Management Studies, and Adjunct Professor, College of Agriculture and Life Sciences (Biotechnology and Genetics), and the College of Engineering (Biomedical Engineering), North Carolina State University (NCSU). He is a Principal at CIMSLogic, Inc. He recently retired as Professor and Executive Director of the BioSciences Management program, Jenkins Graduate School of Management, NCSU. Dr. Kouri helps companies working in the life sciences to learn and practice innovation management; of special interest is the use of big data analytics to inform decision-making. He has helped co-found eleven start-up companies; with three going on to their IPO and three being acquired. Dr. Kouri has helped raise over $221M in private capital for these companies and has written and has been awarded over $24M in research funds including $4.5M in Small Business Innovation Research grants. The value of the six companies that have had exits to date totaled $775M.
Dr. Kouri received the BS degree (Microbiology) from Ohio State University, MS and Ph.D. degrees (Radiation Biology) from the University of Tennessee and was a fellow at Hoffman-LaRoche Pharmaceuticals. Dr. Kouri is an author of 109 publications, 62 abstracts, six patents and four books.